Q3 2025 Management View CEO Christopher Simon reported third-quarter revenue of $349 million, a 4% increase on a reported basis, with adjusted EPS rising 14% to $1.19. He highlighted the company's ...
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...